Zhou, Y., Chen, P., Wang, J., Jin, Y., Li, Y., Chen, C., Qiu, H., Shen, Y., Qiao, Q., Liu, H., Huang, E., Xie, L., Deng, Y., Chen, X., Yang, L., Zhang, L., Liao, X., Lei, Z., Zhang, T., Qiu, M. (2025). A multicenter randomized phase II trial assessing the efficacy and safety of mCapOX plus cetuximab and mFOLFOX6 plus cetuximab as first-line treatment for patients with RAS/BRAF wild-type metastatic colorectal cancer: Primary results of the CAPCET study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.3563